Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorder in Complete Remission in Response to Treatment”

61 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 61 results

Large-scale testing (Phase 3)UnknownNCT00408408
What this trial is testing

Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery

Who this might be right for
Breast Cancer
NSABP Foundation Inc 1,206
Post-approval studies (Phase 4)Not Yet RecruitingNCT07093931
What this trial is testing

Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer

Who this might be right for
Breast Cancer
Shandong Cancer Hospital and Institute 468
Testing effectiveness (Phase 2)Ended earlyNCT03029611
What this trial is testing

IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery

Who this might be right for
Stage III Fallopian Tube CancerStage III Ovarian CancerStage III Primary Peritoneal Cancer+12 more
University of Washington 11
Not applicableUnknownNCT04273477
What this trial is testing

Radiomics-based Artificial Intelligence System to Predict Neoadjuvant Treatment Response in Rectal Cancer

Who this might be right for
Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 100
Testing effectiveness (Phase 2)UnknownNCT01047969
What this trial is testing

Avoiding Surgery in Rectal Cancer After Pre-Operative Therapy

Who this might be right for
Rectal Adenocarcinoma
Royal Marsden NHS Foundation Trust 99
Testing effectiveness (Phase 2)Study completedNCT00535470
What this trial is testing

An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides

Who this might be right for
Mycosis Fungoides
Yaupon Therapeutics 100
Not applicableNot Yet RecruitingNCT07404228
What this trial is testing

Multidimensional Study Designed to Develop a Methodological Framework Based on MRI Data to Predict Pathological Complete Response (pCR) in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Treatment

Who this might be right for
Rectal CancerChemoradiotherapyMri
Institut du Cancer de Montpellier - Val d'Aurelle 115
Large-scale testing (Phase 3)Active Not RecruitingNCT04229979
What this trial is testing

Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2

Who this might be right for
Acute Myeloid Leukemia
Sellas Life Sciences Group 127
Early research (Phase 1)Looking for participantsNCT06130995
What this trial is testing

Relugolix + Enzalutamide Study in High-Risk Prostate Cancer

Who this might be right for
Androgen Deprivation TherapyLocally Advanced Prostate Cancer
University of Oklahoma 46
Post-approval studies (Phase 4)Study completedNCT01243489
What this trial is testing

Compliance: Role Emerges for Success in Chronic Myelogenous Leukaemia (CML): Evaluation aND Optimisation

Who this might be right for
Chronic Myelogenous Leukemia (CML)
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 104
Large-scale testing (Phase 3)Not Yet RecruitingNCT07134218
What this trial is testing

Neoadjuvant Chemoradiotherapy Combined With Immunotherapy and Anti-angiogenesis in Treating Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Changhai Hospital 180
Large-scale testing (Phase 3)Ended earlyNCT00418574
What this trial is testing

Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients

Who this might be right for
Ovarian Cancer
Menarini Group 888
Not applicableLooking for participantsNCT07289282
What this trial is testing

Circulating microRNAs and Response to Neoadjuvant Chemotherapy in Breast Cancer

Who this might be right for
Breast CancerNeoadjuvant TherapyPathological Response+2 more
Atlas University 80
Testing effectiveness (Phase 2)Study completedNCT02789254
What this trial is testing

FLYSYN in MRD Positive AML

Who this might be right for
Acute Myeloid Leukemia
Synimmune GmbH 31
Large-scale testing (Phase 3)Looking for participantsNCT06393374
What this trial is testing

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Who this might be right for
Triple-Negative Breast Cancer
Merck Sharp & Dohme LLC 1,530
Not applicableStudy completedNCT00939666
What this trial is testing

Minimal Invasive Strategies for Good and Complete Response to Chemoradiation in Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Maastricht University Medical Center 28
Large-scale testing (Phase 3)Study completedNCT01757535
What this trial is testing

Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission

Who this might be right for
Leukemia, Myeloid, Acute
Celgene 472
Large-scale testing (Phase 3)Looking for participantsNCT06724237
What this trial is testing

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeFollicular Helper T-Cell LymphomaFollicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type+1 more
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00377429
What this trial is testing

Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy

Who this might be right for
Ovarian Cancer
Neovii Biotech 47
Not applicableLooking for participantsNCT06364371
What this trial is testing

Dynamic Multi-omics Integration Model to Predict Neoadjuvant Therapy Response in Locally Advanced Rectal Cancer

Who this might be right for
Predictive Cancer ModelPathologic Complete Response
Sixth Affiliated Hospital, Sun Yat-sen University 106
Next Page
294